Trial of Pembrolizumab for HIV-Positive Patients with Recurrent or Refractory Cancer
Thomas Uldrick, M.D. (left), of the Cancer Immunotherapy Trials Network, and Robert Yarchoan, M.D. (right), of NCI's HIV and AIDS...
Read more »Thomas Uldrick, M.D. (left), of the Cancer Immunotherapy Trials Network, and Robert Yarchoan, M.D. (right), of NCI's HIV and AIDS...
Read more »Compared with the general population, people infected with HIV are at higher risk for several types of cancer. A fact sheet that descri...
Read more »